DigitalHealth InvestorTalk Show

Steven Wardell

Looking at key digital health industry topics from the investor perspective. New show starting April 2024.

  1. FEB 14

    What's Happening at ViVE in February? With Adam Kaufman and Steven Wardell

    We look at what to expect from the ViVE Conference in Los Angeles in February, including innovations and investor sentiments Adam and I offer a preview of the state of digital-health fundraising, enterprise budgets, and innovation that we'll see at the ViVE conference covering payers and providers. Will the barbell fundraising environment continue? What will be the favored investment themes? Are rollups picking up steam? When will the great shakeout arrive? What will happen to the Zombiecorns? In this show we'll cover: What to do now to prepare for the ViVE Conference in FebruaryHow to get the most out of your time and out of meetingsViews on the future of the fundraising, consolidation, and IPO environments for digital health in 2026And we'll answer your questions. Adam Kaufman is the publisher of BearingOn.Health, an advisor to health systems, pharma companies, and innovative digital health companies, and an adjunct professor of economics at USC. Follow him at: https://www.linkedin.com/in/adkaufman/. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com. Subscribe to the podcast! Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

    1h 11m
  2. JAN 29

    DigitalHealth InvestorTalk: Strategic Alternatives for Zombicorns

    What's next for funded companies with growth issues? After the euphoria of the Zero Interest Rate Period (ZIRP) when many companies received significant funding at high valuations, reality has set in for many of those companies. Slower than expected growth, missed milestones, and a more selective funding environment are forcing tough choices on the management teams of these companies. In this show we'll cover: The changing opportunities and challenges for digital health companiesThe investors' perspectivesThe range of strategic alternatives available to companies And we'll answer your questions. Ron Razmi, MD, is the Managing Director of Zoi, a health AI advisory and investment firm, and the author of AI Doctor: The Rise of Artificial Intelligence in Healthcare. A cardiologist by training, he was previously a McKinsey consultant and CEO of health technology company. He currently writes a column for Fast Company and the The AI Doctor Blog on substack, and comments regularly on CNBC, Fox Business, and other media outlets on the health economy. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com. Subscribe to the podcast! Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

    1h 22m
  3. JAN 12

    What Next-Gen MedTech Brings to Longevity with Lana Caron and Steven Wardell

    Building on advances in technology, MedTech is increasingly able to solve health problems and give us more changes for a long life. From spotting health emergencies earlier to replacing failing organs, the investment potential for the sector is growing. In this show we'll cover: - New technologies enabling medtech - Surprising new capabilities in heatlhcare - The ways that medtech will solve aging And we'll answer your questions. Lana Caron Lana Caron is a medtech and digital health veteran on a mission to make aging optional and longevity mandatory. As a General Partner at Solas BioVentures, she invests in medtech and biopharma innovations poised to transform how long and how well we live. Previously, she led digital health and AI investments at Philips Ventures and held leadership roles at medtech companies innovating to improve our lives. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell. Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com. Subscribe to the podcast! Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

    1h 17m
  4. 12/08/2025

    GenAI Is Revolutionizing Pharmacy with Harry Travis and Steven Wardell

    Pharmacy was based on pills, and PBMs were based on margins. GenAI challenges both. The practice and business of pharmacy is one of the most, if not the most, data intense medical professions and therefore is more susceptible to disruptive AI than any other healthcare profession. In this show we'll cover: How AI is freeing pharmacy operation teams from the tyranny of the screens.There are dozens of early-stage companies powered by AI tools that are working to automate or optimize every step in the process of filling a prescription and determining the appropriate insurance coverage.Over $1 billion dollars in capital has been invested in this space over the past three years.Drug companies are launching Direct to Consumer websites for their patented medicines. How do these work and will they provide better access for patients?Will Most Favored Nations pricing have an effect on drug pricesAnd we'll answer your questions. Harry Travis is the President of The Travis Group. He provides strategic consulting and executive coaching services to both US-based and international clients in the pharmacy, digital medicine, and medical technology markets. He is also the founder of TheRxRoundtable.com, which is a network of expert advisors to the pharmacy and pharmacy technology space. Prior to founding The Travis Group, he was Senior Vice President, Member Services Operations at CVS Caremark. Harry also held senior leadership positions with Baxter Healthcare, Cardinal Health, Accredo/Medco, and Aetna, where he served as the VP of Aetna’s Specialty and Home-Delivery Pharmacy business. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

    1h 20m
  5. 12/02/2025

    Should You Avoid Being a Medical Device? With Steven Wardell and Joe Schwendt

    What's the line for being classified as a medical device? Is it worth it today to be a medical device? What is going on in medtech? What's the line for being classified as a Medical Device? Is it worth it today to be a medical device? What is going on in medtech? The promise of Medical Devices used to be that it wasn't that hard to provide great clinical value for an unmet medical need with a new device and with an straightforward FDA process you could have a high-growth, high-margin product. But what is the real opportunity today? In this show we'll cover: What are the challenges facing Medical Devices today?What are the tradeoffs to avoiding or choosing the medical device pathway?What is the real cost difference?How does AI come into play? And we'll answer your questions. Joe Schwendt is the Founder and CEO of Runway Hero, a boutique consultancy that helps MedTech and Pharma teams build modern medical device software fast, compliant, and inspection-ready. With three decades in regulated digital products, he turns concepts into validated releases with clean documentation, disciplined engineering, and clear business outcomes. Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

    1h 20m
5
out of 5
2 Ratings

About

Looking at key digital health industry topics from the investor perspective. New show starting April 2024.

You Might Also Like